FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy and safety of FOLFIRI regimen with irinotecan
monodrug in the treatment of advanced colorectal cancer patients in the second-line setting.